Table 1.
Distribution of total, invasive and amphotericin B (AMB)-resistant C. kefyr strains detected among clinical yeast isolates collected during 2011–2018 in Kuwait.
Table 2.
Distribution of C. kefyr in different clinical specimens obtained from male and female patients in Kuwait.
Table 3.
In vitro susceptibilities of C. kefyr isolates to four antifungal agents as determined by Etest.
Fig 1.
Dendrogram based on unweighted pair group method with arithmetic mean (UPGMA) and derived from intergenic spacer (IGS)-1 sequence data for 27 C. kefyr isolates.
The source of isolation and susceptibility to amphotericin B (AMB) are also shown for each isolate.